CeQur® announced the appointment of Peter B. Luther to its board of directors, effective immediately. Luther is a 29-year veteran of the medical device and diagnostics, OTC drugs and consumer-packaged goods industries.
One Drop, a leader in the development of digital therapeutics solutions for people with diabetes and related conditions, today announced a partnership with Amazon's exclusive health brand, Choice. Through this partnership, One Drop and Amazon's Choice will bring affordable, accessible, and comprehensive digital health management services to Amazon's Choice customers living with diabetes and hypertension nationwide.
#institution
#bgm
#mobile app
Abbott will announce its first-quarter 2019 financial results on Wednesday, April 17, 2019, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.
Over the last week, San Francisco-based Vida Health’s consumer and member digital health coaching programs have seen the rollout of a personalized behavior recommendation and reminder tool powered by machine learning. In addition, the company is announcing later today a new coaching program focused on healthy sleeping, both as a standalone offering and as a module supporting its other services for managing chronic diseases.
#coaching
Voluntis, a company specializing in digital therapeutics, announces its revenues and annual results for the year ended December 31, 2018. Accordingly, Insulia’s deployment has gained momentum in the U.S., as it is deployed in in healthcare centers in 13 states. In Canada and Germany, Insulia is currently being evaluated in pilot programs. In France, Insulia is being deployed in conjunction with Diabeo, providing healthcare professionals with digital therapeutics across the entire insulin treatment pathway.
Health2Sync, a leader in diabetes management, has partnered with CTBC Bank and Bitmark to establish the world's first diabetes data trust; a secure, yet transparent ecosystem which streamlines diabetes research projects while ensuring the privacy of patients' data. Diabetes research participants can now use Health2Sync's HealthPass mobile app, armored by Bitmark's blockchain-secured technology, to securely upload their medical data into the diabetes data trust.
#r&d
#mobile app
David Weingard, CEO of Cecelia Health, a leading technology-enabled diabetes and related chronic disease management company based in New York City, has been recognized in MM&M's 2019 class of Top 40 Healthcare Transformers.
Global digital therapeutics innovator, DarioHealth Corp. (Nasdaq: DRIO), today announced a joint marketing agreement with Glytec, the market leader and pioneer of insulin titration solutions for use across the full continuum of care. The agreement allows DarioHealth’s smart glucose meter (part of the Dario Blood Glucose Monitoring System) to transmit information to Glytec’s Glucommander™ Outpatient software-as-a-medical-device.
#connected device
#bgm
dacadoo, a global leader in health engagement and Changing Health, a pioneer in behaviour change programmes for people with long term medical conditions announce a global strategic cooperation. The collaboration expands dacadoo’s expertise in promoting wellness using digital tools to people with long term medical conditions to clients and takes Changing Health’s UK approach to international audiences.
#product & service
#mobile app
Nemaura Medical, Inc., a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today provided the following letter to shareholders from the Company’s CEO, Dr. Faz Chowdhury, following the Company’s recent shareholder meeting held on Friday, March 22, 2019